Benefits of Strategic Partnerships, Licensing & Acquisitions API
In the fast-moving drug development industry, securing the right strategic partnerships is crucial for growth and competitive advantage. The Strategic Partnerships, Licensing & Acquisitions API enables:
Early Identification:
Spot promising assets before competitors capitalise on emerging opportunities
Better Evaluation:
Conduct data-driven due diligence with comprehensive drug and company insights
Faster Decisions:
Automate opportunity screening and analysis to accelerate deal-making
Deal Intelligence:
Access insights into deal structures, valuations, and industry investment trends
Streamlined Process:
Eliminate manual data gathering and focus on high-value strategic activities
Portfolio Alignment:
Identify external opportunities that match pipeline needs and business goals
Overview of Strategic Partnerships, Licensing & Acquisitions API
The Strategic Partnerships, Licensing & Acquisitions API is available for each of our Beacon datasets (e.g. ADC, RNA), enabling seamless integration of Beacon data into your internal systems and dashboards.
What Data?
- Comprehensive drug pipeline data covering highest phase of development, therapeutic class, targets, and disease indication
- Clinical trial data including sponsors, collaborators, and trial status
- Deal data including announcements, deal type, terms, potential values, and exclusivity terms
- Company information including, developer type, headcount range, headquarters location, founding date, and areas of interest
- Date of first reference: When commercial intent to develop asset was publicly disclosed
- Modality-specific data across your selected Beacon dataset(s), including ADC, RNA, Cell Therapy, and more
How Does it Work?
- Integrate Beacon’s curated scientific data directly into your analytics tools and dashboards
- Your integration journey will be supported by comprehensive API documentation, user guides, and FAQs
Who Is It For?
Designed specifically for drug developers, the Strategic Partnerships, Licensing & Acquisitions API serves Business Development, External Innovation, and Alliance Management teams responsible for identifying strategic partnerships and making data-driven licensing and acquisition decisions
Gain a Competitive Advantage Throughout the R&D Process
Screen Strategic Opportunities
Portfolio Gap Analysis
Conduct Initial Due Diligence
Why Choose Beacon APIs?
- Structured Data Format: Consistent tagging and formatting for seamless integration
- Comprehensive Documentation:
- Quick Start Guide to get you familiar with Beacon’s APIs and help you to make your first requests to the Beacon database.
- Swagger documentation
- Schemas showing how data is structured
- Example code
- FAQs and Help Guide
- Interoperability: Works with tools like Power BI, Spotfire, Salesforce, and more
- Developer-Friendly Tools: Bruno collection for easy API exploration without coding and Sandbox environment for development or evaluation purposes
- Onboarding & Support from the Beacon Tech team
- Beacon Data: The same accuracy, comprehensiveness and granularity as our Beacon Database Solutions
- Custom Solutions: Hanson Wade Intelligence, our market research and scientific consulting service, can work with you to create custom dashboards and analytics solutions to meet your specific needs and business goals
Related Beacon APIs
Beacon Competitive Landscape API
Beacon Benchmarking & Pipeline Prioritization API
Empower Your Drug Development with Cutting-Edge Data Solutions
Beacon ADC
Complete transparency into the ADC drug development landscape
- Unrivalled comprehensive & accurate pre-clinical & clinical ADC drug, trial and commercial data
- Access to 3,300+ Drugs, 3,800+ Trials, 2,000+ Companies, and 2,000+ Deals in the ADC space
- Market leading ontologies, enabling precise navigation of specific ADC technologies
- Manually curated by ADC scientists, with data updated daily
Beacon Bispecific
Complete transparency into the Bispecific drug development landscape
- Unrivalled comprehensive & accurate pre-clinical and clinical Bispecific therapeutic drug, trial and commercial data
- Access to 3,400+ Drugs, 2,700+ Trials, 2,000+ Companies, and 2,000+ Deals in the Bispecific space
- Market leading ontologies, enabling precise navigation of specific Bispecifics
- Manually curated by Bispecific scientists, with data updated daily
Beacon Cancer Vaccine
Complete transparency into the Cancer Vaccine development landscape
- Unrivalled comprehensive & accurate pre-clinical and clinical Cancer Vaccine drug, trial and commercial data
- Access to 1,700+ Drugs, 1,600+ Trials, 1,300+ Companies, and 1,100+ Deals in the Cancer Vaccine space
- Market leading ontologies, enabling precise navigation of specific Cancer Vaccines
- Manually curated by Cancer Vaccine scientists, with data updated daily
Beacon Cell Therapy
Complete transparency into the Cell Therapy development landscape
- Unrivalled comprehensive & accurate pre-clinical and clinical Cell Therapy drug, trial and commercial data
- Access to 7,000+ Drugs, 5,500+ Trials, 3,000+ Companies, and 3,000+ Deals in the Cell Therapy space
- Market leading ontologies, enabling precise navigation of specific Cell Therapies
- Manually curated by Cell Therapy scientists, with data updated daily
Beacon Checkpoint
Complete transparency into the Checkpoint drug development landscape
- Unrivalled comprehensive & accurate pre-clinical and clinical Checkpoint drug, trial and commercial data
- Access to 2,000+ Drugs, 14,000+ Trials, 2,000+ Companies, and 2,000+ Deals in the Checkpoint space
- Market leading ontologies, enabling precise navigation of specific Checkpoint therapeutics
- Manually curated by Checkpoint scientists, with data updated daily
Beacon Cytokine
Complete transparency into the Cytokine drug development landscape
- Unrivalled comprehensive & accurate pre-clinical and clinical Cytokine drug, trial and commercial data
- Access to 3,000+ Drugs, 9,000+ Trials, 3,000+ Companies, and 3,000+ Deals in the Cytokine space
- Market leading ontologies, enabling precise navigation of specific Cytokine targeting therapies
- Manually curated by Cytokine scientists, with data updated daily
Beacon DDR
Complete transparency into the DDR drug development landscape
- Unrivalled comprehensive & accurate pre-clinical and clinical DDR drug, trial and commercial data
- Access to 800+ Drugs, 1,800+ Trials, 900+ Companies, and 600+ Deals in the DDR space
- Market leading ontologies, enabling precise navigation of the DDR drug development landscape
- Manually curated by DDR scientists, with data updated daily
Beacon Gene Therapy
Complete transparency into the Gene Therapy drug development landscape
- Unrivalled comprehensive & accurate pre-clinical and clinical Cell Therapy drug, trial and commercial data
- Access to 2,600+ Drugs, 1,100+ Trials, 1,800+ Companies, and 1,900+ Deals in the Cell Therapy space
- Market leading ontologies, enabling precise navigation of specific Cell Therapies
- Manually curated by Cell Therapy scientists, with data updated daily
Beacon Immune Tolerance
Complete transparency into the Immune Tolerance drug development landscape
- Unrivalled comprehensive & accurate pre-clinical and clinical Immune Tolerance drug, trial and commercial data
- Access to 6,500+ Drugs, 13,000+ Trials, 6,100+ Companies, and 6,600+ Deals in the Immune Tolerance space
- Market leading ontologies, enabling precise navigation of specific Immune Tolerance therapies
- Manually curated by Immune Tolerance scientists, with data updated daily
Beacon Microbiome
Complete transparency into the Microbiome drug development landscape
- Unrivalled comprehensive & accurate pre-clinical and clinical Microbiome drug, trial and commercial data
- Access to 1,000+ Drugs, 800+ Trials, 850+ Companies, and 650+ Deals in the Microbiome space
- Market leading ontologies, enabling precise navigation of the Microbiome drug development landscape
- Manually curated by Microbiome scientists, with data updated daily
Beacon Oncology
Complete transparency into the Oncology drug development landscape
- Unrivalled comprehensive & accurate pre-clinical and clinical Oncology drug, trial and commercial data
- Access to 25,000+ Drugs, 50,000+ Trials, 8,500+ Companies, and 15,500+ Deals in the Oncology space
- Market leading ontologies, enabling precise navigation the Oncology drug development landscape
- Manually curated by Oncology scientists, with data updated daily
Beacon Oncolytic Viruses
Complete transparency into the Oncolytic Viruses drug development landscape
- Unrivalled comprehensive & accurate pre-clinical and clinical Oncolytic Virus drug, trial and commercial data
- Access to 650+ Drugs, 600+ Trials, 550+ Companies, and 450+ Deals Oncolytic Virus space
- Market leading ontologies, enabling precise navigation of specific Oncolytic Virus
- Manually curated by Oncolytic Virus scientists, with data updated daily
Beacon RNA
Complete transparency into the RNA drug development landscape
- Unrivalled comprehensive & accurate pre-clinical and clinical RNA therapeutic drug, trial and commercial data
- Access to 5,000+ Drugs, 2,000+ Trials, 2,500+ Companies, and 2,500+ Deals in the RNA Therapeutic space
- Market leading ontologies, enabling precise navigation of specific RNA therapeutics
- Manually curated by RNA scientists, with data updated daily
Beacon TPD
Complete transparency into the TPD drug development landscape
- Unrivalled comprehensive & accurate pre-clinical and clinical TPD drug, trial and commercial data
- Access to 1,900+ Drugs, 800+ Trials, 3,200+ Companies, and 900+ Deals in the TPD space
- Market leading ontologies, enabling precise navigation of the TPD drug development landscape
- Manually curated by TPD scientists, with data updated daily
About Beacon
We are a clinical trial and pipeline database solution, designed in partnership with pharmaceutical professionals. We track targeted therapies to provide accurate, in-depth and real-time information in the rapidly evolving landscape of drug development.
See how our clinical trials and drug database solutions in action.
